[Translation] A multicenter, randomized, double-blind, placebo, parallel-controlled clinical trial evaluating the efficacy and safety of NT-002 capsules in the treatment of chronic kidney disease stage 3 or 4 secondary hyperparathyroidism with vitamin D insufficiency in China test
主要目的:评估NT-002胶囊治疗CKD 3期或4期伴VDI的SHPT患者的有效性。
次要目的:评估NT-002胶囊治疗CKD 3期或4期伴VDI的SHPT患者的安全性。
[Translation] Main objective: To evaluate the efficacy of NT-002 capsules in the treatment of SHPT patients with CKD stage 3 or 4 with VDI.
Secondary objective: To evaluate the safety of NT-002 capsules in the treatment of SHPT patients with CKD stage 3 or 4 with VDI.